CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Itolizumab-Plasmapheresis in patients with COVID-19	30/06/2021	Registered
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV	30/06/2016	Registered
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)	30/04/2018	Registered
Nimotuzumab-pancreatic cancer-adults-Phase IV.	30/04/2017	Registered
Predictor of response with CIMAvax EGF© in NSCLC Phase III	29/01/2016	Registered
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)	28/12/2018	Registered outdated
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer	28/11/2016	Registered
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer.	26/05/2014	Registered
Itolizumab Safety and Efficacy Study in Covid 19	26/03/2021	Registered
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus	23/12/2016	Registered
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer.	23/05/2014	Registered
hR3 in metastatic or recurrent colorectal cancer	22/11/2013	Registered
CIMAvax-EGF in patients at high risk of lung cancer	22/10/2020	Registered outdated
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant	22/09/2022	Registered
Safety and effect of Itolizumab in extracorporeal circulation, phase I/II	22/08/2024	Registered
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations	22/05/2021	Registered outdated
Itolizumab for Relapsing Remitting Multiple Sclerosis	22/05/2015	Registered
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II	22/04/2016	Registered
Nimotuzumab in Esophagus premalignant lesions	21/06/2024	Registered
VSSPs in renal carcinoma.	21/06/2023	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources